Metrovacesa 향후 성장
Future 기준 점검 0/6
Metrovacesa (는) 각각 연간 2.1% 및 2.4% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 1.7% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 6.2% 로 예상됩니다.
핵심 정보
2.1%
이익 성장률
1.71%
EPS 성장률
| Real Estate 이익 성장 | -1.0% |
| 매출 성장률 | 2.4% |
| 향후 자기자본이익률 | 6.15% |
| 애널리스트 커버리지 | Low |
| 마지막 업데이트 | 29 Apr 2026 |
최근 향후 성장 업데이트
Recent updates
내러티브 업데이트 • May 02
MVC: Slightly Higher Required Return And Rich P/E Will Constrain Future Upside
Analysts have kept their average price target for Metrovacesa broadly steady around €10.81, citing only slight shifts in discount rate, profit margin assumptions and future P/E expectations rather than any major change in the investment case. Valuation Changes Fair Value: The €10.81 fair value estimate is unchanged, indicating a stable central valuation point in the model.내러티브 업데이트 • Apr 17
MVC: Higher Required Return And Rich P/E Will Pressure Future Returns
Analysts have kept their price target for Metrovacesa broadly unchanged at around €10.81 per share. The latest revisions reflect only very small model tweaks to the discount rate, revenue growth, profit margin and future P/E assumptions, rather than any shift in their core view.내러티브 업데이트 • Apr 03
MVC: Stable Assumptions And Discount Rate Tweaks Will Guide Future Returns
Analysts keep their Metrovacesa price target steady at €10.81, indicating largely unchanged assumptions on fair value, growth, margins, and future P/E, with only minor adjustments to discount rates and long-term expectations. Valuation Changes Fair Value: €10.81 per share is unchanged, suggesting the core view of what the stock is worth on a fundamental basis remains the same.내러티브 업데이트 • Mar 20
MVC: Dividend Outlook And Revised Assumptions Will Shape Future Return Balance
Analysts now set their fair value estimate for Metrovacesa at €10.81 per share, up from €10.63. This reflects updated assumptions around the discount rate, revenue growth, profit margin and future P/E.
내러티브 업데이트 • Mar 06
MVC: Lower Growth Assumptions And Elevated P/E Will Sustain Bearish View
Analysts have modestly lowered their price target on Metrovacesa to €9.30, citing updated assumptions for revenue growth, profit margins and the future P/E multiple, while keeping their fair value estimate unchanged at €9.30. Valuation Changes Fair Value: The fair value estimate is unchanged at €9.30 per share, indicating no revision to the overall valuation outcome.내러티브 업데이트 • Feb 20
MVC: Dividend Outlook And Updated Assumptions Will Shape Future Return Balance
Analysts have slightly trimmed their fair value estimate for Metrovacesa from €10.83 to €10.63, citing updated assumptions around discount rates, expected revenue growth, margins and future P/E levels. Valuation Changes Fair Value: Trimmed slightly from €10.83 to €10.63 per share.내러티브 업데이트 • Feb 06
MVC: Lower Discount Rate And High P/E Will Sustain Bearish View
Analysts have slightly raised their price target on Metrovacesa, citing updated assumptions for the discount rate, revenue growth, profit margins and future P/E, which together indicate a modestly higher fair value per share in euro terms. Valuation Changes Fair Value: unchanged at €9.30 per share.내러티브 업데이트 • Jan 23
MVC: Dividend Reserve Plans And P/E Revisions Will Guide Cautious Outlook
Analysts have maintained their Metrovacesa fair value target at €9.30, citing a combination of updated assumptions that include slightly lower discount rates, higher revenue growth expectations, softer profit margins and a higher future P/E multiple in their latest models. What's in the News Metrovacesa has scheduled a Special and Extraordinary Shareholders Meeting for November 25, 2025, at 13:00 Central European Standard Time in Madrid, Spain (Key Developments).
내러티브 업데이트 • Jan 08
MVC: Dividend Proposal At Extraordinary Meeting Will Support Bullish Thesis
Analysts have revised their price target on Metrovacesa from €11.80 to €13.10, citing updated assumptions around discount rates, revenue growth, profit margins, and the future P/E multiple. What's in the News Metrovacesa has scheduled a Special and Extraordinary Shareholders Meeting for November 25, 2025, at 13:00 Central European Standard Time in Madrid, Spain (calle principe de vergara 187, plaza de rodrigo uria, madrid) (Key Developments) The meeting agenda includes a proposal to discuss the distribution of dividends from freely distributable reserves, which may be relevant if you are focusing on potential cash returns to shareholders (Key Developments) The notice also refers to discussion of other matters at the meeting, indicating that additional shareholder topics could be addressed beyond dividends (Key Developments) Valuation Changes Fair Value Estimate was revised from €11.80 to €13.10, indicating a higher assessed value per share.내러티브 업데이트 • Dec 24
MVC: Dividend Reserve Plans Will Shape A Cautious Medium-Term Outlook
Analysts have raised their price target on Metrovacesa from €6.50 to €9.30, citing higher expected revenue growth, improved profit margins, and a modestly richer future P/E multiple, despite a slightly higher discount rate. What's in the News Metrovacesa has called a special shareholders meeting for November 25, 2025, at 13:00 CET in Madrid to address key corporate matters.분석 기사 • Dec 20
Metrovacesa S.A. (BME:MVC) Shares Could Be 23% Below Their Intrinsic Value Estimate
Key Insights Metrovacesa's estimated fair value is €11.52 based on 2 Stage Free Cash Flow to Equity Current share price...내러티브 업데이트 • Dec 10
MVC: Dividend Decision And Revised Outlook Will Shape Balanced Return Prospects
Analysts have raised their price target on Metrovacesa from €9.81 to €10.83, citing a higher long term fair value despite moderating assumptions for revenue growth, profit margins and future earnings multiples. What's in the News Metrovacesa has scheduled a special and extraordinary shareholders meeting for November 25, 2025, at 13:00 Central European Standard Time in Madrid, Spain (Key Developments) The main agenda item for the upcoming meeting is the potential distribution of dividends from freely distributable reserves, which could affect shareholder returns policy (Key Developments) Shareholders will also address other unspecified matters at the meeting, leaving scope for additional corporate or capital structure decisions (Key Developments) Valuation Changes Fair Value: raised slightly from €9.81 to €10.83 per share, reflecting a modest uplift in long term valuation.분석 기사 • Oct 02
Should You Think About Buying Metrovacesa S.A. (BME:MVC) Now?
Metrovacesa S.A. ( BME:MVC ), is not the largest company out there, but it had a relatively subdued couple of weeks in...분석 기사 • Jul 25
Calculating The Fair Value Of Metrovacesa S.A. (BME:MVC)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Metrovacesa fair value estimate is €12.58 Metrovacesa's €10.15...분석 기사 • May 04
Does Metrovacesa (BME:MVC) Have A Healthy Balance Sheet?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...분석 기사 • Apr 12
Are Investors Undervaluing Metrovacesa S.A. (BME:MVC) By 40%?
Key Insights The projected fair value for Metrovacesa is €16.96 based on 2 Stage Free Cash Flow to Equity Metrovacesa...분석 기사 • Feb 26
Metrovacesa's (BME:MVC) Performance Is Even Better Than Its Earnings Suggest
Even though Metrovacesa S.A.'s ( BME:MVC ) recent earnings release was robust, the market didn't seem to notice. We...
새로운 내러티브 • Feb 19
Will Leverage Undersupplied Spanish Housing Market For Future Opportunities
High presales coverage allows focus on margin maximization, boosting future net margins amid an undersupplied market.분석 기사 • Feb 07
Is It Time To Consider Buying Metrovacesa S.A. (BME:MVC)?
While Metrovacesa S.A. ( BME:MVC ) might not have the largest market cap around , it maintained its current share price...분석 기사 • Dec 13
An Intrinsic Calculation For Metrovacesa S.A. (BME:MVC) Suggests It's 44% Undervalued
Key Insights Metrovacesa's estimated fair value is €16.39 based on 2 Stage Free Cash Flow to Equity Metrovacesa's €9.13...분석 기사 • Sep 12
Estimating The Fair Value Of Metrovacesa S.A. (BME:MVC)
Key Insights The projected fair value for Metrovacesa is €9.93 based on 2 Stage Free Cash Flow to Equity Metrovacesa's...분석 기사 • Aug 01
We Think Metrovacesa's (BME:MVC) Profit Is Only A Baseline For What They Can Achieve
The subdued stock price reaction suggests that Metrovacesa S.A.'s ( BME:MVC ) strong earnings didn't offer any...분석 기사 • Jul 17
Is Now An Opportune Moment To Examine Metrovacesa S.A. (BME:MVC)?
While Metrovacesa S.A. ( BME:MVC ) might not have the largest market cap around , it saw significant share price...분석 기사 • May 28
A Look At The Intrinsic Value Of Metrovacesa S.A. (BME:MVC)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Metrovacesa fair value estimate is €9.31 Current share price...분석 기사 • May 01
We Think Metrovacesa (BME:MVC) Can Stay On Top Of Its Debt
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...분석 기사 • Mar 27
Is Now An Opportune Moment To Examine Metrovacesa S.A. (BME:MVC)?
While Metrovacesa S.A. ( BME:MVC ) might not have the largest market cap around , it received a lot of attention from a...분석 기사 • Feb 12
A Look At The Fair Value Of Metrovacesa S.A. (BME:MVC)
Key Insights The projected fair value for Metrovacesa is €9.08 based on 2 Stage Free Cash Flow to Equity Current share...분석 기사 • Nov 05
Does Metrovacesa (BME:MVC) Have A Healthy Balance Sheet?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...분석 기사 • Jul 05
These 4 Measures Indicate That Metrovacesa (BME:MVC) Is Using Debt Extensively
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...분석 기사 • May 21
Is Now An Opportune Moment To Examine Metrovacesa S.A. (BME:MVC)?
While Metrovacesa S.A. ( BME:MVC ) might not be the most widely known stock at the moment, it saw significant share...분석 기사 • Apr 19
Estimating The Intrinsic Value Of Metrovacesa S.A. (BME:MVC)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Metrovacesa fair value estimate is €7.36 Current share price...분석 기사 • Dec 02
Does Metrovacesa (BME:MVC) Have A Healthy Balance Sheet?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...분석 기사 • Sep 23
Is It Too Late To Consider Buying Metrovacesa S.A. (BME:MVC)?
While Metrovacesa S.A. ( BME:MVC ) might not be the most widely known stock at the moment, it received a lot of...분석 기사 • May 19
Estimating The Intrinsic Value Of Metrovacesa S.A. (BME:MVC)
Does the May share price for Metrovacesa S.A. ( BME:MVC ) reflect what it's really worth? Today, we will estimate the...분석 기사 • Mar 05
Metrovacesa's (BME:MVC) Strong Earnings Are Of Good Quality
Metrovacesa S.A. ( BME:MVC ) just reported healthy earnings but the stock price didn't move much. We think that...분석 기사 • Feb 16
Would Metrovacesa (BME:MVC) Be Better Off With Less Debt?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...분석 기사 • Oct 05
Does Metrovacesa (BME:MVC) Have A Healthy Balance Sheet?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...분석 기사 • Jul 02
Is Metrovacesa S.A. (BME:MVC) Worth €6.7 Based On Its Intrinsic Value?
Today we will run through one way of estimating the intrinsic value of Metrovacesa S.A. ( BME:MVC ) by projecting its...분석 기사 • May 06
Is Metrovacesa (BME:MVC) Using Too Much Debt?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...분석 기사 • Apr 06
Is Metrovacesa S.A. (BME:MVC) A Strong Dividend Stock?
Is Metrovacesa S.A. ( BME:MVC ) a good dividend stock? How can we tell? Dividend paying companies with growing earnings...분석 기사 • Mar 15
Metrovacesa (BME:MVC) Share Prices Have Dropped 51% In The Last Three Years
Metrovacesa S.A. ( BME:MVC ) shareholders should be happy to see the share price up 12% in the last month. But that...분석 기사 • Feb 16
Loss-Making Metrovacesa S.A. (BME:MVC) Set To Breakeven
We feel now is a pretty good time to analyse Metrovacesa S.A.'s ( BME:MVC ) business as it appears the company may be...분석 기사 • Jan 26
When Should You Buy Metrovacesa S.A. (BME:MVC)?
Metrovacesa S.A. ( BME:MVC ), might not be a large cap stock, but it led the BME gainers with a relatively large price...분석 기사 • Jan 05
A Look At The Fair Value Of Metrovacesa S.A. (BME:MVC)
In this article we are going to estimate the intrinsic value of Metrovacesa S.A. ( BME:MVC ) by taking the expected...분석 기사 • Dec 14
If You Had Bought Metrovacesa's (BME:MVC) Shares A Year Ago You Would Be Down 24%
Metrovacesa S.A. ( BME:MVC ) shareholders should be happy to see the share price up 11% in the last month. But that...이익 및 매출 성장 예측
| 날짜 | 매출 | 이익 | 자유현금흐름 | 영업현금흐름 | 평균 애널리스트 수 |
|---|---|---|---|---|---|
| 12/31/2028 | 757 | 62 | 198 | 125 | 2 |
| 12/31/2027 | 780 | 64 | 198 | 184 | 2 |
| 12/31/2026 | 745 | 66 | 183 | 187 | 2 |
| 12/31/2025 | 708 | 57 | 217 | 217 | N/A |
| 9/30/2025 | 632 | 27 | 124 | 124 | N/A |
| 6/30/2025 | 555 | -3 | 31 | 31 | N/A |
| 3/31/2025 | 604 | 6 | 63 | 63 | N/A |
| 12/31/2024 | 653 | 16 | 95 | 95 | N/A |
| 9/30/2024 | 651 | 17 | 75 | 75 | N/A |
| 6/30/2024 | 649 | 18 | 55 | 55 | N/A |
| 3/31/2024 | 616 | -15 | N/A | N/A | N/A |
| 12/31/2023 | 581 | -21 | 32 | 32 | N/A |
| 9/30/2023 | 535 | -68 | N/A | N/A | N/A |
| 6/30/2023 | 430 | -71 | 92 | 92 | N/A |
| 3/31/2023 | 454 | -38 | N/A | N/A | N/A |
| 12/31/2022 | 516 | -23 | 211 | 211 | N/A |
| 9/30/2022 | 529 | 25 | N/A | N/A | N/A |
| 6/30/2022 | 572 | 33 | 227 | 227 | N/A |
| 3/31/2022 | 575 | 31 | N/A | N/A | N/A |
| 12/31/2021 | 512 | 18 | 139 | 139 | N/A |
| 9/30/2021 | 413 | -71 | N/A | N/A | N/A |
| 6/30/2021 | 231 | -90 | -24 | -24 | N/A |
| 3/31/2021 | 138 | -160 | N/A | N/A | N/A |
| 12/31/2020 | 140 | -164 | -78 | -78 | N/A |
| 9/30/2020 | 164 | -87 | N/A | N/A | N/A |
| 6/30/2020 | 180 | -87 | -46 | -45 | N/A |
| 3/31/2020 | 214 | -6 | N/A | N/A | N/A |
| 12/31/2019 | 161 | -4 | -29 | -28 | N/A |
| 9/30/2019 | 206 | 0 | N/A | -15 | N/A |
| 6/30/2019 | 220 | 5 | N/A | 18 | N/A |
| 3/31/2019 | 211 | -11 | N/A | 21 | N/A |
| 12/31/2018 | 190 | -9 | N/A | 35 | N/A |
| 9/30/2018 | 103 | -14 | N/A | 147 | N/A |
| 6/30/2018 | 70 | -31 | N/A | -19 | N/A |
| 3/31/2018 | 34 | -34 | N/A | -38 | N/A |
| 12/31/2017 | 28 | -39 | N/A | -27 | N/A |
| 9/30/2017 | 29 | -55 | N/A | -172 | N/A |
| 12/31/2016 | 21 | -21 | N/A | 21 | N/A |
| 12/31/2015 | 36 | 64 | N/A | -62 | N/A |
애널리스트 향후 성장 전망
수입 대 저축률: MVC 의 연간 예상 수익 증가율(2.1%)이 saving rate(2.7%) 미만입니다.
수익 vs 시장: MVC 의 연간 수익(2.1%)이 Spanish 시장(11.6%)보다 느리게 성장할 것으로 예상됩니다.
고성장 수익: MVC 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.
수익 대 시장: MVC 의 수익(연간 2.4%)이 Spanish 시장(연간 6.4%)보다 느리게 성장할 것으로 예상됩니다.
고성장 매출: MVC 의 수익(연간 2.4%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.
주당순이익 성장 예측
향후 자기자본이익률
미래 ROE: MVC의 자본 수익률은 3년 후 6.2%로 낮을 것으로 예상됩니다.
성장 기업 찾아보기
기업 분석 및 재무 데이터 상태
| 데이터 | 최종 업데이트 (UTC 시간) |
|---|---|
| 기업 분석 | 2026/05/21 04:17 |
| 종가 | 2026/05/21 00:00 |
| 수익 | 2025/12/31 |
| 연간 수익 | 2025/12/31 |
데이터 소스
당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.
| 패키지 | 데이터 | 기간 | 미국 소스 예시 * |
|---|---|---|---|
| 기업 재무제표 | 10년 |
| |
| 분석가 컨센서스 추정치 | +3년 |
|
|
| 시장 가격 | 30년 |
| |
| 지분 구조 | 10년 |
| |
| 경영진 | 10년 |
| |
| 주요 개발 | 10년 |
|
* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.
별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.
분석 모델 및 스노우플레이크
이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.
Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.
산업 및 섹터 지표
산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.
분석가 소스
Metrovacesa S.A.는 22명의 분석가가 다루고 있습니다. 이 중 2명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
| 분석가 | 기관 |
|---|---|
| Ignacio Romero | Banco de Sabadell. S.A. |
| null null | Banco de Sabadell. S.A. |
| Mariano Miguel Hidalgo | Banco Santander |